Literature DB >> 17877597

Predicting a failed induction.

Michael Beckmann1.   

Abstract

BACKGROUND: A failed induction usually refers to failure to progress to the active phase of labour; however, there is no consensus regarding when an induction has failed. AIMS: To investigate the factors (particularly length of latent phase) that may influence mode of birth for women undergoing Syntocinon induction of labour.
METHODS: A retrospective analysis of 978 nulliparous women undergoing Syntocinon induction of labour following artificial or spontaneous rupture of membranes was performed.
RESULTS: As the length of the latent phase increased, the likelihood of birth by caesarean section increased significantly (P < 0.001). After ten hours of Syntocinon administration, the 8% of women not in the active phase of labour had approximately a 75% chance of being delivered by emergency caesarean section and after 12 h the chance was almost 90%. Multivariate analysis also suggested an association between birth by caesarean section and use of prostaglandin gel (P < 0.001) or mechanical methods of cervical priming (P = 0.004), maternal height < 155 cm (P = 0.020) and cervical dilation prior to commencement of Syntocinon (P = 0.018).
CONCLUSIONS: It would seem reasonable to continue a Syntocinon infusion for at least ten hours in women undergoing induction who have yet to reach the active phase of labour ( 4 cm), and unclear benefit in continuing an induction beyond 12 h. The duration of latent phase is a helpful predictor of subsequent mode of birth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877597     DOI: 10.1111/j.1479-828X.2007.00763.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  1 in total

1.  Outcome of Induction and Associated Factors among Term and Post-Term Mothers Managed at Jimma University Specialized Hospital: A Two Years' Retrospective Analysis.

Authors:  Woubishet Girma; Fitsum Tseadu; Mirkuzie Wolde
Journal:  Ethiop J Health Sci       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.